# Diabeloop

> Automated insulin delivery system

Business model and tags: B2B, AI-native, Has physical offices, Venture-backed, Manufacturing, Healthtech, AI & machine learning, Hardware, Sales-led purchase, Pharma & life sciences, Medical devices, International operations, Has in-house R&D, Sells through distributors, Handles regulated data, Has a mobile app

## About Diabeloop

Developing intelligent therapeutic systems for diabetes management, including the first automated insulin delivery device, available in multiple European countries

## Key facts

- **Industry**: Medical Equipment Manufacturing
- **Company size**: 51–250 employees
- **Headquarters**: Grenoble, Auvergne-Rhône-Alpes, France
- **Founded**: 2015
- **Revenue**: €12.9M – €102M (Tamtam estimate)
- **Website**: [diabeloop.com](https://www.diabeloop.com/)
- **LinkedIn**: [linkedin.com/company/diabeloop](https://www.linkedin.com/company/diabeloop)

## Diabeloop in the news

- [Diabeloop announces the completion of its balance sheet restructuring and looks ahead to the next phase of its development](https://www.financialcontent.com/article/getnews-2026-10-21-diabeloop-announces-the-completion-of-its-balance-sheet-restructuring-and-looks-ahead-to-the-next-phase-of-its-development) · financialcontent.com · Oct 21, 2026
  Diabeloop has completed its financial restructuring, is expanding the European rollout of its DBLG2 automated insulin delivery system, and developing new features and broader indications for its technology.
- [Diabeloop Announces the Completion of Its Balance Sheet Restructuring and Looks Ahead to the Next Phase of Its Development](https://greatreporter.com/2026/10/21/diabeloop-announces-the-completion-of-its-balance-sheet-restructuring-and-looks/) · greatreporter.com · Oct 21, 2026
  Diabeloop completed debt restructuring, exited safeguard proceedings, and is now focusing on the commercial rollout of DBLG2 and expanding its technology.
- [Diabeloop et Glooko : le système DBLG1 s’ouvre à la télésurveillance via Glooko XT® en France](https://greatreporter.com/2026/07/17/diabeloop-et-glooko-le-systeme-dblg1-souvre-a-la-telesurveillance-via-glooko-xt-en-france/) · greatreporter.com · Jul 17, 2026
  Diabeloop's DBLG1 automated insulin delivery system now integrates with Glooko XT® for remote diabetes monitoring in France, improving patient follow-up and clinical analysis.

[See all 20 articles](https://www.tamtam.ai/c/diabeloop/news)

## Diabeloop at a glance

Diabeloop is a B2B company in the Medical Equipment Manufacturing industry, headquartered in Grenoble, Auvergne-Rhône-Alpes, France.

Diabeloop was founded in 2015.

Diabeloop has 51–250 employees.

Diabeloop's revenue is €12.9M – €102M (Tamtam estimate).

## Frequently asked questions about Diabeloop

### What is Diabeloop's revenue?

Tamtam estimates Diabeloop's annual revenue at €12.9M – €102M.

### How many employees does Diabeloop have?

Diabeloop has 51–250 employees.

### Where is Diabeloop headquartered?

Diabeloop is headquartered in Grenoble, Auvergne-Rhône-Alpes, France.

---

Company data compiled by Tamtam from public sources and Tamtam's own analysis. Figures marked as estimates are modelled, not reported.

Source: https://www.tamtam.ai/c/diabeloop
